The neutral connective infrastructure for compounded medicine.
PEPTPlus connects prescribers to vetted compounding pharmacies, neutrally. Rules-based matching, NCPDP SCRIPT e-prescribing, and end-to-end fulfillment tracking, on flat subscriptions with $0 tied to the drug. A live platform, ready to transact today.
A booming market with no map
Compounded medicine is surging, driven by persistent drug shortages, the GLP-1 / peptide boom, and personalized care. Yet thousands of compounding pharmacies have no shared directory and no neutral way to be found or compared, while a wave of quality scrutiny makes verification table stakes. The cost: delayed therapies, inconsistent access, and the best-suited pharmacy never reached.
We replace guesswork with infrastructure
PEPTPlus brings vetted compounding pharmacies into one connected network and matches each patient to the right pharmacy, neutrally. Flat subscription pricing, no per-prescription cut, no share of drug cost. We never profit from steering a script, which is precisely what makes both sides trust the rails.
One connected workflow
A single workflow serving prescribers and pharmacies alike.
Discover
Vetted compounding pharmacies in one place, not word of mouth.
Match
A neutral, rules-based engine pairs each patient to a fit pharmacy. No pay-to-play.
e-Prescribe
Transmit electronically via the industry-standard NCPDP SCRIPT format.
Track
Follow fulfillment in one place; the pharmacy stays pharmacy of record.
Neutral by design
Revenue is decoupled from prescription volume and drug cost; ARR grows with seats, not drug spend. Neutrality isn't just a value; it's the business model, and the foundation of a defensible, two-sided network. The full defensibility thesis lives in the data room.
Live platform. Real workflow.
- Platform in production: prescriber, pharmacy, lab & admin experiences built end-to-end
- NCPDP SCRIPT e-prescribing and the neutral matching engine, live
- Flat-fee, neutral revenue model in place: $0 tied to the drug
- Ready for prescribers and pharmacies to transact today
Why now
- Demand is here today; the neutral infrastructure to serve it safely is not here yet
- Quality scrutiny makes verification & traceability table stakes
- First-mover on the neutral position, before the category consolidates
- An 18-month plan to turn on the two-sided flywheel (detailed in the data room)
Founders, board & advisors
Operators at the intersection of healthcare and software, building the trusted, neutral rails for compounded medicine.
Healthcare-marketplace and digital-health operator. Leads vision, fundraising, and pharmacy partnerships.
Health-tech engineering leader. Built our NCPDP SCRIPT e-prescribing and the neutral matching engine.
An independent director with healthcare and pharmacy-operations experience is being added to the board.
Appointment pendingPharmacy (503A / 503B) and compliance expertise; guides verification standards and quality.
Appointment pendingCompounding-pharmacy operations and quality leadership across 503A / 503B networks.
Appointment pendingScaling two-sided healthcare marketplaces and prescriber adoption.
Appointment pendingWhat's in the data room
We keep the numbers where they belong: with qualified, accredited investors. Request access and we'll share:
Financial model & projections
Bottom-up ARR build, margins, and the path to a self-sustaining network.
Market & opportunity
TAM / SAM / SOM, the beachhead strategy, and the 18-month go-to-market plan.
Moat & round terms
The defensibility thesis, traction detail, the raise, valuation, and use of funds.
Interested in investing?
Accredited investors only. Submit the form and our team will follow up with the data room: the financial model, market sizing, the moat thesis, and the round terms.
This page is for informational purposes only and is not an offer to sell or a solicitation of an offer to buy any securities. Any offering will be made only to eligible investors (e.g., accredited investors under Reg D) pursuant to definitive documents and the PEPTPlus LLC Operating Agreement. Market statistics are from third-party sources.
Forward-looking statements. Certain statements on this page are forward-looking, including statements about our platform's capabilities, features, third-party integrations (such as e-prescribing and EHR connectivity), roadmap, market opportunity, and timing. Some described capabilities may be in development, in pilot, or planned rather than generally available, and depend on factors including third-party certification (e.g., e-prescribing network and EPCS requirements), regulatory conditions, and execution risk. Forward-looking statements and projections are estimates based on current expectations, involve known and unknown risks, are not guarantees of future performance, and actual results may differ materially. We undertake no obligation to update them except as required by law.